Establishment of an oxaliplatin-resistant human colon carcinoma HCT116/L-OHP cell and preliminary exploration for the mechanism of resistance

Tumor

Volumn 31, Issue 8, 2011, Pages 675681-

  Lu, Hai ^a   Sun, Jue ^a   Xu, Jian Hua ^a   Fan, Zhong Ze ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cell, HCT116; Colorectal neoplasms; Drug resistance, multiple; Oxaliplatin

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CISPLATIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; OXALIPLATIN; PERMEABILITY GLYCOPROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL CYCLE; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; CROSS RESISTANCE; DRUG CYTOTOXICITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 80052206062     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2011.08.001     Document Type: Article

References (11)

1. RAYMOND E, CHANEY S G, TAAMMA A, et al . Oxaliplatin: a review of preclinical and clinical studies[J]. Ann Oncol , 1998, 9(10): 1053-1071.
2. TAKARA K, SAKAEDA T, OKUMURA K. An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy[J]. Curr Pharm Des , 2006, 12(3): 273-286.
3. HOUR T C, CHEN J , HUANG C Y , e t a l . Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines[J]. Anticancer Res , 2000, 20(5A): 3221-3225.
4. O'CONNELL M J, WALWORTH N C, CARR A M. The G2-phase DNA-damage checkpoint[J]. Trends Cell Biol , 2000, 10(7): 296-303.
5. CHÈNE P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy[J]. Nat Rev Cancer , 2003, 3(2): 102-109.
6. MIWA S, UCHIDA C, KITAGAWA K, et al . Mdm2- mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner[J]. Biochem Biophys Res Commun , 2006, 340(1): 54-61.
7. ABDEL-FATTAH G, YOFFE B, KRISHNAN B, et al . MDM2/p53 protein expression in the development of colorectal adenocarcinoma[J]. J Gastrointest Surg , 2000, 4(1): 109-114.
8. LIANG H, ATKINS H, ABDEL-FATTAH R, et al . Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs[J]. Gene , 2004, 338(2): 217-223.